Table 1 The clinico-pathological characteristics of patients with primary operable invasive ductal breast cancer (n = 360)
Clinico-pathological characteristics | Patients, n (%) |
|---|---|
Age (≤50/ >50 years) | 125(35%)/235(65%) |
Size (≤20/ 21-50/ >50 mm) | 185(51%)/162(45%)/13(4%) |
Grade (I / II / III) | 48(13%)/124(34%)/188(52%) |
Involved lymph node (-ve/+ve) | 206(57%)/154(43%) |
ER status (no/yes) | 171(47%)/189(53%) |
PR status (no/yes) | 194(54%)/166(46%) |
HER2 status (no/yes) | 289(80%)/71(20%) |
Triple-negative tumours (no/yes) | 240(67%)/120(33%) |
Endocrine therapy (no/yes/unknown) | 272(76%)/81(22%)/7(2%) |
Chemotherapy (no/yes/unknown) | 209(58%)/144(40%)/7(2) |
Tumour recurrence (no/local/distant/both) | 271(75%)/17(5%)/67(19%)/5(1%) |
Alive/cancer death/non cancer death | 189(53%)/97(27%)/74(21%) |